JavaScript is disabled for your browser. Some features of this site may not work without it.
| dc.contributor.author | Jacobs, T.
|
|
| dc.contributor.author | Kgokolo, Mahlatse C.M.
|
|
| dc.date.accessioned | 2021-11-25T08:26:33Z | |
| dc.date.available | 2021-11-25T08:26:33Z | |
| dc.date.issued | 2020-12 | |
| dc.description.abstract | Psoriasis is a prevalent chronic inflammatory disease. Beyond skin and joint manifestations, psoriasis has numerous associated comorbidities, including metabolic and cardiovascular disease. There are many treatment options available, from topical treatment for mild psoriasis, phototherapy for moderate disease, to systemic therapy or biological agents for severe disease. This article aims to focus on the treatment for the majority of patients where topical agents alone are generally appropriate. | en_ZA |
| dc.description.department | Dental Management Sciences | en_ZA |
| dc.description.librarian | am2021 | en_ZA |
| dc.description.uri | http://www.sapj.co.za/index.php/sapj | en_ZA |
| dc.identifier.citation | Jacobs, T. & Kgokolo, C.M. 2020, 'Treatment of psoriasis', SA Pharmaceutical Journal, vol. 87, no. 6, pp. 23-26. | en_ZA |
| dc.identifier.issn | 1015-1362 | |
| dc.identifier.uri | http://hdl.handle.net/2263/82841 | |
| dc.language.iso | en | en_ZA |
| dc.publisher | Medpharm Publications | en_ZA |
| dc.rights | This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 2.5 South Africa License. | en_ZA |
| dc.subject | Psoriasis | en_ZA |
| dc.subject | Chronic inflammatory disease | en_ZA |
| dc.subject | Comorbidities | en_ZA |
| dc.subject | Treatment | en_ZA |
| dc.subject.other | Health sciences articles SDG-03 | |
| dc.subject.other | SDG-03: Good health and well-being | |
| dc.title | Treatment of psoriasis | en_ZA |
| dc.type | Article | en_ZA |
